Search clinical trials for: 68Ga-DOTATATE PET scan

Total 1282 results

Centre for Addiction and Mental Health

Not yet recruiting

Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

Schizophrenia | Schizophreniform Disorders

Canada
Centre Hospitalier Intercommunal de Toulon La Seyne...
Monaco Scientific center

Recruiting

Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease (SPECTRE)

Atherosclerosis

Monaco
Memorial Sloan Kettering Cancer Center

Recruiting

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Cancer | Metastatic Pancreatic Ductal Adenocarcinoma | Primary Pancreatic Ductal Adenocarcinoma

United States
Aaron Ritter, MD

Terminated

The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)

Inflammation | Parkinson Disease | Alzheimer Disease

United States
Assistance Publique Hopitaux De Marseille

Completed

Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study

Adrenal Tumors

France
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Subjects With Early Symptomatic AD

Alzheimer Disease

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Glioblastoma

United States
Innovaderm Research Inc.
Icahn School of Medicine at Mount Sinai; Montreal Heart Institute

Completed

Trial on Vascular Inflammation in Atopic Dermatitis

Atopic Dermatitis | Coronary Atherosclerosis | Vascular Inflammation

Canada
M.D. Anderson Cancer Center
GE Healthcare

Withdrawn

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Advanced Cancers
Mayo Clinic

Not yet recruiting

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

WHO Grade 3 Glioma | WHO Grade 2 Glioma | WHO Grade 4 Glioma

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

Melanoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Head and Neck Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Colon Cancer | Malignant Neoplasm

United States
NYU Langone Health

Completed

Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI

Nasopharyngeal Cancer

United States
University Health Network, Toronto

Completed

PET CT Re-Planning NSCLC (4DCT-PET)

Non-Small Cell Lung Cancer | Lung Cancer
Mayo Clinic

Completed

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Hepatocellular Carcinoma

United States
UMC Utrecht

Not yet recruiting

FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype (FoCus)

Metastatic Colorectal Cancer | Metastatic Cancer to Liver
Fifth Affiliated Hospital, Sun Yat-Sen University

Recruiting

Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Positron-Emission Tomography

China
Avid Radiopharmaceuticals

Completed

Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

Corticobasal Degeneration | Progressive Supranuclear Palsy

United States
Stanford University

Completed

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

Primary Malignant Liver Neoplasm

United States
Institut Curie

Not yet recruiting

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT) (FAP-IT)

Triple Negative Breast Cancer
University of Edinburgh
NHS Lothian; British Heart Foundation

Completed

Metabolic Imaging in Carotid Atherosclerosis (MICA)

Stroke | Atherosclerosis

United Kingdom
Peking University Cancer Hospital & Institute

Unknown

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

Lymphoma | Positron-Emission Tomography | Tumor, Solid

China
Memorial Sloan Kettering Cancer Center

Completed

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Head and Neck Cancer

United States
Life Molecular Imaging SA

Terminated

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Prostate Cancer

Austria, Finland
Universitaire Ziekenhuizen KU Leuven

Recruiting

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

Status Epilepticus | Positron-emission Tomography | Ictal-interictal Continuum | Perfusion Weighted MRI | Perfusion CT

Belgium
Jonsson Comprehensive Cancer Center

Not yet recruiting

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Prostate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Metastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8

United States
University of California, San Francisco
Radiological Society of North America

Completed

68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

Ovarian Carcinoma

United States
Aplagon Oy
TRACER Europe BV

Recruiting

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography) (CHASE)

Peripheral Arterial Occlusive Disease | Critical Limb Ischemia

Netherlands
Enrico Novelli
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

Sickle Cell Disease

United States
Singapore General Hospital
National University Hospital, Singapore; Tan Tock Seng Hospital; Nanyang Technological... and other collaborators

Recruiting

Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease (Pre Med SSc GI)

Systemic Sclerosis | Scleroderma

Singapore
Rigshospitalet, Denmark

Completed

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Cervix Cancer

Denmark
Avid Radiopharmaceuticals

Completed

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

Alzheimer Disease

United States
Institut Curie
Roche Pharma AG; National Research Agency, France

Not yet recruiting

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Triple Negative Breast Cancer

France
Amsterdam UMC, location VUmc
Leiden University Medical Center; Dutch Cancer Society

Recruiting

[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer (PANSCAN-1)

Pancreatic Cancer | Cholangiocarcinoma

Netherlands
Indiana University

Completed

PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer

Prostate Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma

United States
The First Affiliated Hospital of Anhui Medical...
National Natural Science Foundation of China

Suspended

FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application

Malignant Tumors | Positron-Emission Tomography

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Recruiting

Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma

Carcinoma, Hepatocellular | Positron-Emission Tomography

China
University of Alberta
Canadian Urological Association Scholarship Foundation

Completed

18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients

Prostate Cancer

Canada
Vanderbilt University Medical Center

Completed

TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH (TYEGER)

Pulmonary Arterial Hypertension

United States
National Institute of Allergy and Infectious Diseases...

Completed

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Pulmonary Tuberculosis

South Africa
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Suspended

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative Neoplasms

United States
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment
Avid Radiopharmaceuticals

Terminated

Flortaucipir 18F PET Imaging in BIOCARD Study

Cognitive Decline

United States
Avid Radiopharmaceuticals
The Cleveland Clinic

Completed

Tau Imaging in Professional Fighters

Alzheimer's Disease

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases

Vasculitis | Dementia | Fever of Unknown Origin | Cardiac Disease | Osteomyelitis | Inflammatory Disease | FDG Avid Cancers

United States
Jonsson Comprehensive Cancer Center

Completed

Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma

United States
Universitaire Ziekenhuizen KU Leuven

Recruiting

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

Prostate Cancer

Belgium
Rigshospitalet, Denmark
Curasight

Completed

Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography (uPAR-PET)

Breast Cancer | Prostate Cancer | Urinary Bladder Cancer

Denmark
Institut National de la Santé Et de la Recherche...

Not yet recruiting

Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study (INSIGHT-2)

Alzheimer Disease | Memory Disorders | Memory Complaint

France

Search clinical trials for: 68Ga-DOTATATE PET scan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations